We are live on ! Find out more
Bridger Management

Bridger Management Portfolio holdings

AUM $150M Turnover 36.67%
1-Year Est. Return 10.57%
This Fund
S&P 500
This Quarter Est. Return
+6.58%
1 Year Est. Return
+10.57%
3 Year Est. Return
+101.66%
5 Year Est. Return
+158.29%
10 Year Est. Return
+911%
AUM
$1.55B
AUM Growth
+$102M
Cap. Flow
+$15.9M
Cap. Flow %
1.03%
Top 10 Hldgs %
47.84%
Holding
47
New
7
Increased
10
Reduced
12
Closed
9
Avg Time Held Equity + Options
1 year
Top 10 Avg Time Held Equity + Options
0.6 years
Top 20 Avg Time Held Equity + Options
0.9 years
Avg Time Held Equity only
1.1 years
Top 10 Avg Time Held Equity only
0.7 years
Top 20 Avg Time Held Equity only
0.9 years

Top Buys

Rank Stock Value
1
MNK
Mallinckrodt
MNK
+$72.5M
2
BIIB icon
Biogen
BIIB
+$58.1M
3
HCA icon
HCA Healthcare
HCA
+$25.7M
4
CF icon
CF Industries
CF
+$16.6M
5
TGTX icon
TG Therapeutics
TGTX
+$15.1M

Sector Composition

Rank Sector Weight
1 Healthcare 61.25%
2 Consumer Discretionary 8.4%
3 Communication Services 8.17%
4 Consumer Staples 5.94%
5 Industrials 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
POST icon
1
Post Holdings
POST
$3.47B
$92M 5.94%
1,700,036
– –
2014 Q4
6 quarters
MGM icon
2
MGM Resorts International
MGM
$8.44B
$89.6M 5.79%
3,958,970
– –
2015 Q2
4 quarters
MDCO
3
DELISTED
Medicines Co
MDCO
$81.1M 5.24%
2,412,501
-688,797
-22% -$24.3M
2014 Q2
8 quarters
LH icon
4
Labcorp
LH
$29.9B
$80M 5.16%
714,561
-57,176
-7% -$6.15M
2014 Q1
9 quarters
IRWD icon
5
Ironwood Pharmaceuticals
IRWD
$768M
$77.4M 5%
7,065,690
+882,408
+14% +$8.62M
2015 Q1
5 quarters
MNK
6
DELISTED
Mallinckrodt
MNK
$72.1M 4.66%
+1,186,046
New +$72.5M
2016 Q2
0 quarters
WMGI
7
DELISTED
Wright Medical Group
WMGI
$69.1M 4.46%
3,979,841
+403,192
+11% +$7.4M
2015 Q3
3 quarters
TEVA icon
8
Teva Pharmaceutical Industries
TEVA
$45.9B
$65.5M 4.23%
1,304,572
+195,998
+18% +$10.4M
2015 Q3
3 quarters
AET
9
DELISTED
Aetna Inc
AET
$57.8M 3.73%
473,099
-86,988
-16% -$10M
2015 Q3
3 quarters
DXCM icon
10
DexCom
DXCM
$30B
$56.2M 3.63%
2,833,580
-503,232
-15% -$8.57M
2015 Q4
2 quarters
CNC icon
11
Centene
CNC
$32B
$54.3M 3.5%
1,520,390
+299,258
+25% +$9.4M
2014 Q3
7 quarters
BIIB icon
12
Biogen
BIIB
$36.6B
$53.3M 3.44%
+220,499
New +$58.1M
2016 Q2
0 quarters
CHTR icon
13
Charter Communications
CHTR
$15.5B
$52.5M 3.39%
229,504
-24,318
-10% -$5.23M
2013 Q2
12 quarters
NKTR icon
14
Nektar Therapeutics
NKTR
$1.14B
$51.2M 3.31%
239,904
+5,437
+2% +$1.22M
2015 Q4
2 quarters
META icon
15
Meta Platforms (Facebook)
META
$1.56T
$48.1M 3.1%
420,598
– –
2013 Q2
12 quarters
GRUB
16
DELISTED
Just Eat Takeaway.com
GRUB
$46.8M 3.02%
753,600
-74,134
-9% -$3.9M
2015 Q3
3 quarters
KSU
17
DELISTED
Kansas City Southern
KSU
$40.5M 2.62%
449,703
-212,504
-32% -$19.3M
2015 Q4
2 quarters
WCG
18
DELISTED
Wellcare Health Plans
WCG
$40.1M 2.59%
374,143
+45,640
+14% +$4.46M
2015 Q2
4 quarters
ALNY icon
19
Alnylam Pharmaceuticals
ALNY
$20B
$38.1M 2.46%
687,009
-110,203
-14% -$6.94M
2013 Q2
12 quarters
PACB icon
20
Pacific Biosciences
PACB
$568M
$36.5M 2.35%
5,182,239
+1,085,362
+26% +$9.9M
2015 Q4
2 quarters
VRSN icon
21
VeriSign
VRSN
$27.5B
$35.6M 2.3%
411,637
– –
2013 Q2
12 quarters
TGTX icon
22
TG Therapeutics
TGTX
$10B
$31.5M 2.04%
5,204,618
+1,859,149
+56% +$15.1M
2013 Q3
11 quarters
LBRDA icon
23
DELISTED
Liberty Broadband Class A
LBRDA
$25.9M 1.67%
435,892
– –
2015 Q2
4 quarters
IONS icon
24
CALL
Ionis Pharmaceuticals
IONS
$4.51B
$25.5M 1.65%
+1,095,000
New +$35.3M
2016 Q2
0 quarters
HCA icon
25
HCA Healthcare
HCA
$96.6B
$25M 1.62%
+325,185
New +$25.7M
2016 Q2
0 quarters

Similar funds

Bridger Management's Q2 2016 Portfolio in Review

As of Q2 2016, Bridger Management held 47 positions worth $1.55B, up 7% from $1.45B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Bridger Management's Q2 2016 filing shows 7 new, 10 increased, 12 reduced and 9 closed positions. Its largest new stake was Mallinckrodt: 1,186,046 shares worth $72.1M. The largest sale was UnitedHealth, an estimated $50.3M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 60% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Bridger Management's largest Q2 2016 buy was Mallinckrodt: 1,186,046 shares worth $72.1M.
  • Bridger Management added most to TG Therapeutics in Q2 2016, an estimated $15.1M increase.
  • Bridger Management's biggest Q2 2016 reduction was Medicines Co, cutting an estimated $24.3M.
  • Bridger Management fully exited UnitedHealth in Q2 2016, selling an estimated $50.3M.
  • Bridger Management's ten largest holdings make up 48% of its $1.55B portfolio in Q2 2016.
  • Bridger Management opened 7 new positions and closed 9 in Q2 2016.
  • Bridger Management's portfolio value rose 7% quarter-over-quarter to $1.55B.

Based on Bridger Management's 13F filing for Q2 2016, filed 15 Aug 2016.